about
Role of mitochondria in alcoholic liver diseaseComparative proteomics study on liver mitochondria of primary biliary cirrhosis mouse modelVitamin E Attenuates the Progression of Non-Alcoholic Fatty Liver Disease Caused by Partial Hepatectomy in MicePGC-1α overexpression results in increased hepatic fatty acid oxidation with reduced triacylglycerol accumulation and secretion.Liver-specific loss of Perilipin 2 alleviates diet-induced hepatic steatosis, inflammation, and fibrosis.CYP2E1-dependent and leptin-mediated hepatic CD57 expression on CD8+ T cells aid progression of environment-linked nonalcoholic steatohepatitis.Reduced hepatic mitochondrial respiration following acute high-fat diet is prevented by PGC-1α overexpression.Gastrointestinal and hepatic manifestations of mitochondrial disorders.Lipid disorder and intrahepatic renin-angiotensin system activation synergistically contribute to non-alcoholic fatty liver disease.Endoplasmic reticulum proteostasis in hepatic steatosis.NAFLD and diabetes mellitus.Highly expressed MT-ND3 positively associated with histological severity of hepatic steatosis.Fatty liver oxidative events monitored by autofluorescence optical diagnosis: Comparison between subnormothermic machine perfusion and conventional cold storage preservation.Celecoxib ameliorates non-alcoholic steatohepatitis in type 2 diabetic rats via suppression of the non-canonical Wnt signaling pathway expression.Emerging role of redox dysregulation in alcoholic and nonalcoholic fatty liver disease.Role of 3-Hydroxy Fatty Acid-Induced Hepatic Lipotoxicity in Acute Fatty Liver of Pregnancy.The beneficial effects of resveratrol on steatosis and mitochondrial oxidative stress in HepG2 cells.Proteomic changes in chicken primary hepatocytes exposed to T-2 toxin are associated with oxidative stress and mitochondrial enhancement.Thymic NF-κB-inducing kinase regulates CD4+ T cell-elicited liver injury and fibrosis in mice.
P2860
Q26864954-9041F341-784B-44FE-86F3-C0D05EA32A0FQ34668643-78AB9FF5-F1BE-4822-B54F-EDEFE4C43673Q35850661-2168E536-450F-4CAE-8A49-2FE5102C1DECQ36312713-2A3BBC41-D3ED-44CA-921A-BF950940F004Q36902259-9CB09597-6086-4616-AD5C-1CD9F22E6459Q37417528-77AF76D4-2007-44E4-AD5D-322A95872054Q37440086-464EDCE4-08E0-4FDE-ACA9-0C11E8C8AE54Q38106894-43250408-909B-4D38-B260-77C8D62FB5BBQ38782387-9E4C8E63-3A36-4D7F-93F0-322EF679FCBBQ38925531-C45E3521-8811-4D87-8919-59B6BF2CD389Q38978347-A3C3ADBA-4363-4849-8CBA-14977233C073Q39097897-31F29B1B-9D70-4E44-AACC-04E1B3F42DB4Q39569591-BD35F4B8-AEDF-4E27-B3F3-71612408E250Q41849677-FE144541-2484-4B62-B634-DAA513027633Q42764666-6FD3D4DD-9B87-4C97-A1A7-13435BC428D9Q47546227-E8884371-5C0D-4A9F-8EC4-938B97293438Q50201534-DB74EFCF-7583-455F-BB7A-B6A33802D0B6Q53090401-E7160F6B-0DE0-4B83-A706-1B6D3AB69D6DQ53712515-CEDB11D0-508B-4CF1-BB68-5E559BBAFA3D
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mitochondria and redox signaling in steatohepatitis
@en
Mitochondria and redox signaling in steatohepatitis.
@nl
type
label
Mitochondria and redox signaling in steatohepatitis
@en
Mitochondria and redox signaling in steatohepatitis.
@nl
prefLabel
Mitochondria and redox signaling in steatohepatitis
@en
Mitochondria and redox signaling in steatohepatitis.
@nl
P2093
P2860
P356
P1476
Mitochondria and redox signaling in steatohepatitis
@en
P2093
E Matthew Morris
Jamal A Ibdah
R Scott Rector
P2860
P304
P356
10.1089/ARS.2010.3795
P577
2011-04-26T00:00:00Z